Woodmont Investment Counsel’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,620
| Closed | -$335K | – | 241 |
|
|
2023
Q3 | $335K | Hold |
6,620
| – | – | 0.04% | 187 |
|
|
2023
Q2 | $309K | Sell |
6,620
-500
| -7% | -$23.3K | 0.03% | 193 |
|
|
2023
Q1 | $272K | Sell |
7,120
-450
| -6% | -$17.2K | 0.03% | 208 |
|
|
2022
Q4 | $415K | Sell |
7,570
-2,050
| -21% | -$112K | 0.05% | 184 |
|
|
2022
Q3 | $328K | Sell |
9,620
-2,500
| -21% | -$85.2K | 0.04% | 197 |
|
|
2022
Q2 | $115K | Buy |
12,120
+2,000
| +20% | +$19K | 0.01% | 235 |
|
|
2022
Q1 | $144K | Buy |
10,120
+500
| +5% | +$7.12K | 0.02% | 241 |
|
|
2021
Q4 | $203K | Buy |
+9,620
| New | +$203K | 0.03% | 212 |
|